BREAKING NEWS
Boy chokes to death after eating more than three pooris together
WhatsApp, Gmail banned from use for transmission of official documents in Jammu and Kashmir
Let truth come out: Kharge on Oppn demand for discussion, JPC on Adani issue
IT employee, lover arrested in murder of Kochi woman
IPL Auction 2025 | GT buy Washington Sundar for Rs 3.20 crore; Shaw, Shardul go unsold
Virat Kohli doesn’t need our support, but we need the support of Kohli: Bumrah
INDIA bloc seeking JPC probe into Adani ‘scam’, govt scared of debate: Congress after LS, RS adjourned
Ranbir on criticism for doing ‘Sanju’, ‘Animal’: Important to dabble in different genres, characters
No ‘formula’ under discussion for CM’s post: Ajit Pawar
Perth Test: Bumrah leads India to its biggest Test win on Australian soil
MNS at risk of losing recognition, symbol after drawing blank in Maharashtra polls
Perth Test, Day 4: Siraj removes Smith as Australia go into lunch at 104 for five
Sambhal violence toll rises to four; prohibitory orders issued, outsiders’ entry barred till Nov 30
Two highway robbers shot at in Hubballi during spot inspection
Ullal: Auto-rickshaw accident near Konaje claims driver’s life
Dr Reddy’s Lab launches generic eye treatment medication in US
PTI, Jan 27, 2023, 5:13 PM IST
Representative Image (Source: Pexels)
New Delhi: Dr Reddy’s Laboratories on Friday said it has launched Difluprednate Ophthalmic Emulsion, used in the treatment of pain and swelling in the eyes caused by infection or allergy after eye surgery, in the American market.
The company has launched the medication, a generic version of Durezol (Difluprednate Ophthalmic Emulsion 0.05 per cent) in the US market, after getting approval from the US Food and Drug Administration (USFDA), the Hyderabad-based drug major said in a statement.
As per IQVIA data, the Durezol brand and generics had sales of around USD 40 million in the US for the most recent twelve months ending in November 2022. Dr Reddy’s shares on Friday ended 2.78 percent up at Rs 4,321.35 apiece on the BSE.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Sensex reclaims 80k mark; Nifty surges over 1% after BJP-led Mahayuti’s win in Maharashtra
Rapid digital expansion to create over 1 lakh new jobs in fiber tech in India in next 5 years
Choose correct ITR to report foreign assets; 2 lakh such returns filed: CBDT official
Air India Express increases flight operations from northeast destinations
Mcap of 8 of top-10 most-valued domestic firms jumps Rs 1.55 lakh cr; HDFC Bank, TCS sparkle
MUST WATCH
Latest Additions
Karnataka: BJP to begin official campaign on Waqf issue from December 4
Geethartha Chinthane 105: Shoka and Dukha are not same
Boy chokes to death after eating more than three pooris together
Internal divisions leave open question whether Gandhi’s vision will ever be fully realised in India: Bill Clinton
PWD, Google Maps officials booked in Bareilly bridge death case
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.